Zimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $2.02, $0.05 better than the analyst estimate of $1.97. Revenue for the quarter came in at $1.93 billion versus the consensus estimate of $1.9 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2016 EPS of $7.90-$8.00, versus prior guidance of $7.85-$8.00 and the consensus of $7.96. Zimmer Biomet Holdings sees FY2016 revenue of $7.68-7.72 billion, versus the consensus of $7.58 billion.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.